Known targets — ChEMBL curated mechanism
S1PR1S1PR2S1PR3S1PR4S1PR5rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Dodecanol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.81 |
| ▸ | TSHR | P16473 | 2/20 | 0.81 |
| ▸ | GLA | P06280 | 1/20 | 0.81 |
| ▸ | HPGD | P15428 | 1/20 | 0.81 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.81 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.81 |
| ▸ | BLM | P54132 | 1/20 | 0.81 |
| ▸ | CA1 | P00915 | 9/20 | 0.50 |
| ▸ | CA2 | P00918 | 9/20 | 0.50 |
| ▸ | CA9 | Q16790 | 8/20 | 0.50 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | CA3 | P07451 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | CA6 | P23280 | 2/20 | 0.50 |
| ▸ | CA5A | P35218 | 2/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dodecanol SCHEMBL10633177 | 1.00 | RECQL (0.81) | RECQLTSHRGLAHPGDMAPK1 | |
| Cetyl Alcohol SCHEMBL6535951 | 1.00 | RECQL (0.81) | RECQLTSHRGLAHPGDMAPK1 | |
| Cetostearyl Alcohol SCHEMBL27583121 | 1.00 | RECQL (0.81) | RECQLTSHRGLAHPGDMAPK1 | |
| Dodecanol SCHEMBL28615994 | 1.00 | RECQL (0.81) | RECQLTSHRGLAHPGDMAPK1 | |
| Undecanol SCHEMBL20335521 | 1.00 | RECQL (0.81) | RECQLTSHRGLAHPGDMAPK1 | |
| Decanol SCHEMBL29144362 | 1.00 | RECQL (0.81) | RECQLTSHRGLAHPGDMAPK1 | |
| Cetostearyl Alcohol SCHEMBL27699331 | 1.00 | RECQL (0.81) | RECQLTSHRGLAHPGDMAPK1 | |
| Cetyl Alcohol SCHEMBL1568837 | 1.00 | RECQL (0.81) | RECQLTSHRGLAHPGDMAPK1 | |
| Cetostearyl Alcohol SCHEMBL18422169 | 1.00 | RECQL (0.81) | RECQLTSHRGLAHPGDMAPK1 | |
| Dodecanol SCHEMBL28101131 | 0.96 | RECQL (0.76) | RECQLTSHRGLAHPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240100058-A1 | METHOD FOR SELECTING, ASSESSING, OR PRODUCING SODIUM LAURYL SULFATE AS RAW MATERIAL FOR PHARMACEUTICAL FORMULATION, OR FORMULATION OR THE LIKE CONTAINING SAME | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-03-28 | — | — | US | claimed |
| CN-111802385-B | Protein product capable of fixing target and removing according to need | 西安曼特思生物科技有限公司 | 2021-08-31 | — | — | CN | claimed |
| US-20240100058-A1 | METHOD FOR SELECTING, ASSESSING, OR PRODUCING SODIUM LAURYL SULFATE AS RAW MATERIAL FOR PHARMACEUTICAL FORMULATION, OR FORMULATION OR THE LIKE CONTAINING SAME | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-03-28 | — | — | US | disclosed |
| WO-2021132541-A1 | METHOD FOR SELECTING, ASSESSING, OR PRODUCING SODIUM LAURYL SULFATE AS RAW MATERIAL FOR PHARMACEUTICAL FORMULATION, OR FORMULATION OR THE LIKE CONTAINING SAME | 中外製薬株式会社 | 2021-07-01 | — | — | WO | disclosed |
| US-10259941-B1 | Microcrystal exfoliation by UV light irradiation | NATIONAL GUARD HEALTH AFFAIRS (SA) | 2019-04-16 | — | — | US | disclosed |
| US-10179857-B1 | Spontaneous peeling of tetragonal microcrystals with short pulses of UV-light | NATIONAL GUARD HEALTH AFFAIRS (SA) | 2019-01-15 | — | — | US | disclosed |
| EP-2099878-A1 | METHODS OF TREATING SUBTERRANEAN FORMATIONS USING HYDROPHOBICALLY MODIFIED POLYMERS AND COMPOSITIONS OF THE SAME | Halliburton Energy Services, Inc. (US) | 2009-09-16 | — | — | EP | disclosed |
| WO-2008068467-A1 | METHODS OF TREATING SUBTERRANEAN FORMATIONS USING HYDROPHOBICALLY MODIFIED POLYMERS AND COMPOSITIONS OF THE SAME | HALLIBURTON ENERGY SERVICES, INC. (US) | 2008-06-12 | — | — | WO | disclosed |
| EP-1438380-A4 | HIGH RETENTION SANITIZER SYSTEMS | FMC CORP (US) | 2004-12-08 | — | — | EP | disclosed |
| US-6828294-B2 | High-retention sanitizer, especially on irregular and/or non-horizontal surfaces and surfaces on which water does not readily spread, a method for sanitizing a surface using the composition, and kits comprising components of the | FMC CORPORATION | 2004-12-07 | — | — | US | disclosed |
| US-20040171507-A1 | High retention sanitizer systems | KELLAR KENNETH E (US) | 2004-09-02 | — | — | US | disclosed |
| EP-1438380-A1 | HIGH RETENTION SANITIZER SYSTEMS | FMC CORPORATION (US) | 2004-07-21 | — | — | EP | disclosed |
| US-20030109405-A1 | High retention sanitizer systems | PEROXYCHEM LLC | 2003-06-12 | — | — | US | disclosed |
| WO-2003014284-A1 | HIGH RETENTION SANITIZER SYSTEMS | FMC CORPORATION (US) | 2003-02-20 | — | — | WO | disclosed |
| US-20020014329-A1 | INTEGRATED HEATING AND COOLING SYSTEM FOR A VEHICLE | INSTATHERM COMPANY | 2002-02-07 | — | — | US | disclosed |
| EP-1091861-A1 | INTEGRATED HEATING AND COOLING SYSTEM FOR A VEHICLE COMPARTMENT COMPRISING A THERMAL STORAGE RESERVOIR AND AN ADDITIONAL HEATER | Instatherm Company (US) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000000361-A9 | INTEGRATED HEATING AND COOLING SYSTEM FOR A VEHICLE COMPARTMENT COMPRISING A THERMAL STORAGE RESERVOIR AND AN ADDITIONAL HEATER | INSTATHERM COMPANY (US) | 2000-05-18 | — | — | WO | disclosed |
| WO-2000000361-A1 | INTEGRATED HEATING AND COOLING SYSTEM FOR A VEHICLE COMPARTMENT COMPRISING A THERMAL STORAGE RESERVOIR AND AN ADDITIONAL HEATER | INSTATHERM COMPANY (US) | 2000-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240100058-A1 | METHOD FOR SELECTING, ASSESSING, OR PRODUCING SODIUM LAURYL SULFATE AS RAW MATERIAL FOR PHARMACEUTICAL FORMULATION, OR FORMULATION OR THE LIKE CONTAINING SAME | S1PR5, LSS, S1PR4 | RECQL 4196/4885TSHR 3747/4885GLA 1941/4885 |
| US-10179857-B1 | Spontaneous peeling of tetragonal microcrystals with short pulses of UV-light | DSG1, MITF, JUP | RECQL 1279/4885TSHR 1930/4885GLA 481/4885 |
| US-10259941-B1 | Microcrystal exfoliation by UV light irradiation | CRY2, ERCC4, MCM7 | RECQL 908/4885TSHR 2820/4885GLA 605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.